Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients
Glycatetd Hemoglobin Index and Red Cell Distribution Width as Prognstic Indicator in Critical Ill Patients
1 other identifier
observational
97
0 countries
N/A
Brief Summary
The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2025
CompletedStudy Start
First participant enrolled
July 5, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 2, 2026
July 9, 2025
June 1, 2025
1.2 years
May 29, 2025
July 7, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Glycated Hemoglobin level
Measurement of Hb level in all patients upon ICU admission.
Baseline
Red Cell Distribution Width (RDW)
Measurement of RDW in all patients upon ICU admission.
baseline
Hemoglobin (Hb) Level
Measurement of Hb level in all patients upon ICU admission.
baseline
Interventions
Hbg and RDW as prognstic indicator in critical ill patients
Eligibility Criteria
All patients except patients in exculcion critira
You may qualify if:
- patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis
- diabtic Patients 3-animic Patients
You may not qualify if:
- Patients under 18 years of age
- ICU stay \< 24 h
- patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
May 29, 2025
First Posted
July 9, 2025
Study Start
July 5, 2025
Primary Completion (Estimated)
August 29, 2026
Study Completion (Estimated)
December 2, 2026
Last Updated
July 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share